2nd Quarter - Report
ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
Income
—
Expenses
$262,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Support for increased FDA funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | — |
| LAUREN LEA FULLER | — |
Medicare/Medicaid MMM
21st century cures (HR 6), Medicare Part D pharmacy drug management programs for at-risk beneficiaries,Biosimilar naming, Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | — |
| LAUREN LEA FULLER | — |
| ADAM PARKER NELSON New | — |
Pharmacy PHA
Biosimilar naming - supporting Congressional action to seek FDA decision on naming and supporting FTC study of effect of naming on competition, Medicare Part D lock in and Medicare Part D issues concerning managed care pharmacy
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | — |
| LAUREN LEA FULLER | — |
| ADAM PARKER NELSON New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.